SAN FRANCISCO, June 5, 2023 /PRNewswire/ — The global home healthcare market size is expected to reach USD 666.9 billion by 2030, according to a report by Grand View Research, Inc., expanding at a CAGR of 7.96% over the forecast period. This growth can be attributed to cost-efficiency, improved patient outcomes, and convenience offered by home … Read more
PUNE, India, June 5, 2023 /PRNewswire/ — According to a recent market study published by Growth Market Reports, titled, “Cell Culture Flasks Market Segments – by Type (50 ML, 250 ML, 600 ML, Others), by Material (Polystyrene, Borosilicate Glass, Polycarbonate, Polypropylene, Others) by Sterility (Sterile, Non-sterile, Others), by Closure Cap (Vented, Screw Cap, Filter, Others), by … Read more
HONG KONG, GERMANTOWN, Md. and SUZHOU, China , June 5, 2023 /PRNewswire/ — Sirnaomics Ltd. (the “Company”, Stock Code: 2257.HK, together with its subsidiaries, the “Group” or “Sirnaomics”), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced the interim results of an ongoing Phase I clinical trial of STP705, an siRNA (small interfering RNA) … Read more
HOUSTON, June 5, 2023 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that Tom Vo, M.D., MBA, Chairman and Chief Executive Officer of Nutex Health is scheduled to … Read more
SUZHOU, China, and ROCKVILLE, Md., June 5, 2023 /PRNewswire/ — Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated results from a Phase II study of MDM2-P53 inhibitor, alrizomadlin (APG-115), in combination with pembrolizumab in patients … Read more
OXFORD, England and KRAKOW, Poland, June 5, 2023 /PRNewswire/ — The University of Oxford and Selvita (WSE: SLV), one of the largest contract research organizations in Europe, announced an integrated drug discovery collaboration in the area of Parkinson’s disease. While Parkinson’s disease is the second most common neurodegenerative disease affecting ~7 million people worldwide, there … Read more
SHENZHEN, China, 5 de junho de 2023 /PRNewswire/ — Em comemoração ao aniversário da empresa, a Kieslect lança os smartwatches Lora2 e Ks Pro. Esses smartwatches exclusivos representam o próximo passo no monitoramento da saúde, bem como na fabricação elegante e de alta qualidade para consumidores conscientes da moda. 20230523094302 Observando o equilíbrio entre moda e … Read more
SHENZHEN, China, 5 de junio de 2023 /PRNewswire/ — Para celebrar el aniversario de la empresa, Kieslect presenta los relojes inteligentes Lora2 y Ks Pro. Estos relojes inteligentes únicos representan el siguiente paso en el control de la salud, así como una fabricación elegante y de alta calidad para los consumidores amantes de la moda. … Read more
NEW YORK, June 5, 2023 /PRNewswire/ — The health intelligent virtual assistant market size is expected to grow by USD 4,396.38 million during 2022-2027, progressing at a CAGR of 39.76% as per the latest Technavio market research report. North America is going to have lucrative growth during the forecast period. About 39% of the market’s overall growth … Read more
– Lunit and Sweden’s largest private hospital pioneering a new approach to combine radiologists’ expertise with AI SEOUL, South Korea, June 5, 2023 /PRNewswire/ — Lunit (KRX:328130.KQ), a leading global provider of AI-powered cancer diagnostic solutions, today announced the signing of a supply and license agreement with Capio S:t Göran Hospital, Stockholm, Sweden. Under the agreement, … Read more